Progress in structure modification of triptolide

Yaoxue Xuebao

Volumn 39, Issue 10, 2004, Pages 857-864

  Zhang, Fan ^a   Li, Yuan Chao ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Pharmacological effect; Structure modification; Tripterygium wilfordii Hook. f.; Triptolide

Indexed keywords

INTERLEUKIN 1; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER INHIBITION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; GRAFT VERSUS HOST REACTION; HUMAN; IC 50; IMMUNOMODULATION; PROTEIN MODIFICATION; REVIEW; STRUCTURE ACTIVITY RELATION; TRIPTERYGIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DITERPENES; HUMANS; PHENANTHRENES; PLANTS, MEDICINAL; TRIPTERYGIUM;

EID: 12344268233     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Editer Committee of National Chinese Medical Manage Bureau "Chinese Herb". Chinese Herb [M]. Vol. 5. Shanghai : Shanghai Science and Technology Press, 1999.206-215.
2. Second Hospital of Samming Region, Fujian Province. Preliminary observation on the therapeutic effect of the peeled roots of Terpterygium wilfordii Hook. F. on rheumatoid arthritis [J]. Med Pharmacol Inf, 1973,1:8-9.
3. Wu L. Glycosides of Terpterygium wilfordii [J]. Chin Pharma Bull, 1984,19(4):25-26.
4. Kupchan SM, Court WA, Daily RG, et al. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Terpterygium wilfordii [J]. J Am Chem Soc, 1972,94(20):7194-7195.
5. Yang SX, Gao HL, Xie SS, et al. Immunosuppression of triptolide and its effect on skin allograft survival [J]. Int J Immunopharmacol, 1992,14(6):963-969.
6. Pei RJ, Qi LH, Liu XJ. Mechanism of immunosuppressive effects of triptolide [J]. Chin Pharmacol Bull, 1993,9(1):68-72.
7. Wang J, Xu R, Fidler JM, et al. Immunosuppressive activity of the Chinese medicinal plant Tripterygium. Wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine [J]. Transplatation, 2000,70(3):447-455.
8. Chen BJ, Liu C, Fidler JM, et al. Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, Through inhibition of alloreactive T cell expansion [J] Transplatation, 2000,70(10):1442-1447.
9. Chen BJ, Chao NJ. Immunosuppressive and anti-inflammatory effects of triptolide and its prodrug PG-490-88 [J]. Drug Future, 2002,27(1):57-60.
10. Yu DQ, Zhang DM, Wang HB, et al. Structure modification of triptolide, a diterpeneoid from Triperygium wilfordii [J]. Acta Pharm Sin, 1992,27 (11):830-836.
11. Lu Y, Zheng Q, Ma P, et al. Fine stereo-structure study on Triperygium wilfordii Hook. F diterpene compounds [J]. Nat Prod Res Dev, 1998, 10(3):1-5.
12. Qi YM, Musser JH. Immunosuppressive compounds and methods [P]. US Pat: 5663335, 1997-09-02
13. Fidler JM, Li K. Anticancer treatment using triplolide prodrugs [P]. US Pat: 6620843, 2003-09-16.
14. Dai D, Fidler JM, Musser JH. Amino acid derivatives of triptolide compounds as immunemodulators and anticancer agents [P]. US Pat: 6569893, 2003-05-27.
15. Musser JH. Triptolide prodrugs having high aqueous solubility [P]. US Pat: 6150539, 2000-11-21.
16. Wang D, Gao X, Li W, et al. Derivatives of triptolide, and preparation and uses thereof [P]. WO: 00/63212, 2000-10-26.
17. Dai D, Yuan H, Musser JH. Triptolide prodrugs having high aqueous solubility [P]. US Pat: 6548537, 2003-04-15.
18. Jung MJ, Wickramaratne M, Hepperle M. Triptolide derivatives useful in the treatment of autoimmune diseases [P]. US Pat: 6004999, 1999-12-21.
19. Jung MJ, Wickramaratne M, Hepperle M. Triptolide derivatives useful in the treatment of autoimmune diseases [P]. US Pat: 5972998, 1999-10-26.